Alpha Tau Medical Ltd. Investing cash flow

Investing cash flow of DRTS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Investing cash flow growth rates and interactive chart.


Highlights and Quick Summary

  • Investing cash flow for the quarter ending June 30, 2023 was $4.97 Million (a -105.53% decrease compared to previous quarter)
  • Year-over-year quarterly Investing cash flow decreased by -98.31%
  • Annual Investing cash flow for 2022 was $-89.9 Million (a -0.0% decrease from previous year)
  • Annual Investing cash flow for 2022 was $-89.9 Million (a -566.64% decrease from previous year)
  • Annual Investing cash flow for 2021 was $19.3 Million (a 0.0% decrease from previous year)
  • Twelve month Investing cash flow ending June 30, 2023 was $209 Million (a 2.44% increase compared to previous quarter)
  • Twelve month trailing Investing cash flow increased by 984.49% year-over-year
Trailing Investing cash flow for the last four month:
30 Jun '23 31 Dec '22 31 Mar '22 31 Dec '21
$209 Million $204 Million $19.6 Million $19.3 Million
Visit stockrow.com/DRTS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Investing cash flow of Alpha Tau Medical Ltd.

Most recent Investing cash flowof DRTS including historical data for past 10 years.

Interactive Chart of Investing cash flow of Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd. Investing cash flow for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $4.97
2022 $-89.94 $-0.3 $-89.94
2021 $294.27 $0.0 $-274.39 $-0.61 $19.27
2020 $0.0 $0.0 $-7.82
2019 $-10.16 $-10.16

Business Profile of Alpha Tau Medical Ltd.

Sector: Healthcare
Industry: Biotechnology